Background: The Yusho poisoning incident, which was caused by rice bran oil contaminated with polychlorinated biphenyls (PCBs), polychlorinated quarterphenyls (PCQs) and polychlorinated dibenzofurans (PCDFs) generated by heat denaturation of PCB, occurred in 1968 in western Japan. Annual physical, dermatological, dental, ophthalmological and laboratory examinations were conducted for Yusho patients after the incident. From 2001, blood levels of individual PCDF congeners were also measured. The blood levels of 2,3,4,7,8-pentachlorodibenzofuran (2,3,4,7,8-PeCDF), PCBs and PCQs in Yusho patients were found to be significantly higher than those of the general population. We investigated the relationships between blood concentrations of 2,3,4,7,8-PeCDF, PCBs and PCQs in Yusho patients and the items measured in the annual medical examination.

Methods: Medical and laboratory examination data from 501 Yusho patients enrolled in the study from 2001 to 2004 were analyzed. The relationships between blood 2,3,4,7,8-PeCDF, PCB and PCQ concentrations and medical/laboratory examination data were investigated using principal components and logistic regression analyses.

Results: Serum Concentrations of 2,3,4,7,8-PeCDF, PCBs and PCQs in blood tended to correlate with either acneform eruptions, black comedones, cutaneous and mucosal pigmentation, and hypersecretion of meibomian glands as well as general fatigue, headaches, cough/sputum, abdominal pain, arthralgia, increased blood sugar, increased serum gamma-GTP and decreased total bilirubin. The majority of these signs and symptoms are included in the diagnostic criteria for Yusho.

Conclusion: After Yusho patients had suffered chronic exposure to these chlorinated compounds for more than 35 years, the serum concentration of 2,3,4,7,8-PeCDF in blood was significantly related to arthralgia and decreased albumin/globulin (A/G) ratio; the serum concentration of PCBs was significantly related to ophthalmologic symptoms; and the serum concentration of PCQ to increased total cholesterol. These findings suggest that the co-contaminants may affect other functions than those originally associated with Yusho.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2572596PMC
http://dx.doi.org/10.1186/1476-069X-7-47DOI Listing

Publication Analysis

Top Keywords

yusho patients
24
23478-pecdf pcbs
12
pcbs pcqs
12
serum concentration
12
yusho
8
serum concentrations
8
polychlorinated biphenyls
8
polychlorinated quarterphenyls
8
blood levels
8
pcqs yusho
8

Similar Publications

Tapinarof is a nonsteroidal, topical, aryl hydrocarbon receptor agonist approved for the treatment of atopic dermatitis (AD) in Japanese patients aged ≥12 years. We evaluated the efficacy and safety of tapinarof in Japanese pediatric patients aged 2 to 11 years with AD in a phase 2, multicenter, randomized, double-blind, vehicle-controlled trial. Eligible patients (N = 121) were randomized 1:1:1 to receive tapinarof cream 0.

View Article and Find Full Text PDF
Article Synopsis
  • Tapinarof cream 1% is a nonsteroidal topical treatment evaluated in two phase 3 trials for Japanese patients aged 12 and older with atopic dermatitis (AD).
  • In trial ZBB4-1, tapinarof showed significantly better outcomes, with 20.24% of patients achieving clear or almost clear skin compared to 2.24% for the vehicle; ZBB4-2 demonstrated ongoing effectiveness over 52 weeks.
  • Most side effects were mild to moderate, and common issues included folliculitis, acne, and headaches, indicating that tapinarof is generally safe for long-term use in treating AD.
View Article and Find Full Text PDF
Article Synopsis
  • - Tapinarof cream (1%) was tested for treating plaque psoriasis in two phase 3 trials involving Japanese patients, showing a significant improvement in psoriasis symptoms compared to a vehicle (inactive treatment).
  • - In the first trial (ZBA4-1), 20.06% of patients using tapinarof achieved high success at week 12 compared to only 2.5% with the vehicle, while in the second trial (ZBA4-2), the treatment success rate increased to 56.3% by week 52.
  • - The treatment was generally safe, with most side effects being mild or moderate, such as folliculitis and contact dermatitis, confirming tapinarof cream's efficacy and safety for
View Article and Find Full Text PDF

Global prevalence of oral pigmentation and its related factors: a systematic review and meta-analysis.

J Stomatol Oral Maxillofac Surg

October 2022

Research Center for Environmental Determinants of Health, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. Electronic address:

Background: Oral pigmentation is due to the accumulation of one or more pigments in tissues, causing changes in the color of the oral mucosal surfaces. Understanding the exact global prevalence of oral pigmentation and its associated factors helps researchers make the proper interventions at the right time; in this respect, the objective of the present systematic review and meta-analysis was to determine the global prevalence of oral pigmentation and its related factors.

Method: A systematic review and meta- analysis were conducted using the following databases: Magiran, SID, Scopus, Embase, PubMed, Web of Science (WoS), and Google Scholar.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!